Compare KBR & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KBR | ITGR |
|---|---|---|
| Founded | 1901 | 1970 |
| Country | United States | United States |
| Employees | 36000 | N/A |
| Industry | Military/Government/Technical | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.3B |
| IPO Year | 2006 | 2000 |
| Metric | KBR | ITGR |
|---|---|---|
| Price | $38.37 | $125.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $52.43 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 1.6M | 1.5M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.83% | N/A |
| EPS Growth | ★ 15.05 | N/A |
| EPS | ★ 1.55 | 1.17 |
| Revenue | ★ $5,767,000,000.00 | $1,853,637,000.00 |
| Revenue This Year | $4.56 | $1.69 |
| Revenue Next Year | $5.11 | $6.53 |
| P/E Ratio | ★ $24.62 | $106.89 |
| Revenue Growth | 2.27 | ★ 7.98 |
| 52 Week Low | $29.94 | $62.00 |
| 52 Week High | $52.23 | $126.14 |
| Indicator | KBR | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 59.13 | 82.68 |
| Support Level | $35.17 | $82.58 |
| Resistance Level | $39.38 | $126.14 |
| Average True Range (ATR) | 1.42 | 2.71 |
| MACD | 0.12 | 0.67 |
| Stochastic Oscillator | 97.20 | 97.01 |
KBR, formerly Kellogg Brown & Root, is a global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: mission technology solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 36,000 people. The firm generated $7.8 billion in revenue in 2025.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.